Skip to content

Supplier News

Unilever sells Alberto VO5, Rave brands

Unilever plans to sell rights to the Alberto VO5 and Rave hair care brands to private equity firm Brynwood Partners VI L.P. The consumer products giant said Wednesday that the divestiture is required by the U.S. Department of Justice in the wake of its $3.7 billion acquisition of the Alberto

Apricus antifungal drug cleared by FDA

NexMed USA, a subsidiary of Apricus Biosciences Inc., has been approved by the Food and Drug Administration to market Tolnaftate-D, the company’s first over-the-counter antifungal medication with its NexACT technology.

Skinvisible’s DermSafe hand sanitizer to launch in Canada

Skinvisible Pharmaceuticals Inc. next month plans to roll out its DermSafe antimicrobial hand sanitizer in Canada. The Las Vegas-based company said Thursday that DermSafe will be launched by Alto Pharmaceuticals in Canada on Sept. 1, in time for the back-to-school and flu seasons.

TCGRx, IAS form partnership for central fill solutions

Pharmacy technology executives Duane Chudy, chief executive officer of TCGRx, and Gene Fellows, CEO of Integrated and Automation Solutions (IAS), have partnered to form CentralRx, which aims to meet the rising industry need for a full-service central pharmacy fill solution provider.

Lannett names vice chairman

Jeffrey Farber has been appointed vice chairman at Lannett Co. The generic drug manufacturer and marketer said Tuesday that the 50-year-old Farber has served as a member of Lannett’s board since May 2006.

GSK Consumer Healthcare names marketing chief

Former Johnson & Johnson executive John Graham has joined GlaxoSmithKline Consumer Healthcare as chief marketing officer. John Graham Starting in the CMO post this week at GlaxoSmithKline, and based in Parsippany, N.J., Graham now oversees GSK Consumer Healthcare’s North American marketing function.